Table I.
Characteristics | N |
---|---|
Age (years) | |
Median | 53 |
Range | 41–61 |
ECOG PS | |
0 | 5 |
1 | 1 |
Clinical tumor stage | |
T2 | 1 |
T3 | 0 |
T4 | 5 |
Clinical nodal status | |
N1 | 1 |
N2 | 3 |
N3 | 2 |
ER receptor status | |
Positive | 3 |
Negative | 3 |
PR receptor status | |
Positive | 2 |
Negative | 4 |
Menopausal status | |
Premenopausal | 3 |
Postmenopausal | 3 |
Treatment cycles | |
Median | 4 |
Range | 3–6 |
Reduction rate (%) | |
Median | 61.9 |
Range | 39.0–69.9 |
ECOG, Eastern Cooperative Oncology Group; PS, performance status; ER, estrogen receptor; PR, progesterone receptor.